The study protocol was successfully pilot tested with N=7 subjects (6 NASA flight surgeons and 1 Behavioral Health and Performance element Operations professional) as subjects from March through June, 2009. The pilot study results supported the scientific feasibility of conducting a randomized, double-blind, placebo controlled study of sleep medication effects on alarm-based awakenings. Preliminary analysis from the pilot study indicated differences in performance upon abrupt awakening between the sleep medication and placebo conditions. Thus, the pilot data also support the likelihood of new scientific and clinical insights from the proposed Phase II studies with NASA astronauts.More »
Protocol to use with astronauts and other NASA personnel (e.g., flight surgeons, flight directors, and flight controllers) to assess potential carry over effects from sleep medications used during spaceflight operations (including overseas training periods), and following an abrupt awakening from sleep.More »
|Organizations Performing Work||Role||Type||Location|
|Johnson Space Center (JSC)||Lead Organization||NASA Center||Houston, TX|
This is a historic project that was completed before the creation of TechPort on October 1, 2012. Available data has been included. This record may contain less data than currently active projects.
A final report document may be available for this project. If you would like to request it, please contact us.